Inhibition of UVB induced DNA photodamage in mouse epidermis by ...

9 downloads 41 Views 278KB Size Report
Apr 16, 1997 - Pyrimidine dimers are specific markers of UV-induced. Ultraviolet B light (UVB*) has been shown to be a complete photodamage and are not ...
Carcinogenesis vol.18 no.8 pp.1617–1622, 1997

Inhibition of UVB induced DNA photodamage in mouse epidermis by topically applied α-tocopherol

Maralee McVean and Daniel C.Liebler1

Ultraviolet B light (UVB*) has been shown to be a complete skin carcinogen (1). Moreover, UVB induced DNA photodamage appears to be a critical event in photocarcinogenesis. Characteristic lesions in UVB irradiated DNA include cyclobutane pyrimidine dimers and pyrimidine (6–4) pyrimidone photoproducts, which form between adjacent pyrimidines (2),

and photohydrates. Pyrimidine dimers can produce deletion, frame shift, and substitution mutations and have been associated with distinctive C→T and CC→TT transitions in the genome (3). Many squamous and basal cell carcinomas contain such characteristic mutations within the p53 tumor suppressor gene (4–6). In sunlight reaching the earth’s surface, it is the UVB portion which contains the most carcinogenic wavelengths. Thus, sunscreening agents ideally scatter, reflect or absorb wavelengths in this range. Many commercial sunscreens contain compounds whose UV absorbances extend into the UVB, such as salicylates, cinnamates, benzophenones, and ester derivatives of p-aminobenzoic acid (PABA). However, chemopreventive agents such as α-tocopherol (αTH, λmax 5 294 nm) also absorb in the UVB region. This absorbance may account in part for the ability of topically applied αTH to suppress UVB induced damage such as cellular release of lysosomal enzymes (7), edema (8,9) and erythema (9). Topical d,l-αtocopherol acetate (αTAc) has also been found to decrease lipid peroxidation and preserve normal replicative DNA synthesis in UVB irradiated hairless mice (10). The efficacy of sunscreens is evaluated primarily on the basis of their ability to prevent erythema and edema (11). These manifestations of UVB exposure result from a number of secondary changes in the dermis and epidermis. Generation of reactive oxygen species (12), vascular changes (13), activation of inflammatory mediators and cells, membrane damage, and release of various cytokines (14) all contribute to these endpoints. From such a complex combination of events, it is difficult to attribute specific molecular protective effects to a sunscreen. Selected sunscreens have been shown to inhibit UV induced DNA damage (15–18), actinic damage (19), and photocarcinogenesis (20). Nevertheless, sunscreens are not routinely evaluated for their ability to prevent nonmelanoma skin cancers and the scope of their photoprotective actions at the molecular level remains largely undefined. This investigation is based on the observation that topical application of αTH prevented skin photocarcinogenesis, whereas application of the tocopherol derivatives αTAc or α-tocopherol succinate (αTS) did not (21,22). This suggests a difference in the extent of protection provided against UVB damage by these closely related compounds and supports the idea that αTH has substantial sunscreening properties. In order to investigate the hypothesis that αTH can act as a sunscreen, we monitored the induction of a UV specific DNA photoproduct. Pyrimidine dimers are specific markers of UV-induced photodamage and are not formed through oxidative mechanisms (23). Here we report that αTH and its derivatives are effective in preventing UVB induced DNA photodamage. Because DNA damage is a critical event in cancer initiation, inhibition of thymine dimer formation is a relevant parameter for assessing the efficacy of topical chemopreventive agents.

*Abbreviations: αTH, α-tocopherol; αTAc, α-tocopherol acetate; αTOMe, α-tocopherol methyl ether; αTS, α-tocopherol succinate; HPLC, high performance liquid chromatography; PABA, p-aminobenzoic acid; SPF, sun protection factor; UVB, ultraviolet B.

Reagents R,R,R-αTH used in these experiments was provided by Henkel Fine Chemicals (LaGrange, IL). d,l-αTAc was purchased from Sigma Chemical Company (St

Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, PO Box 210207, Tucson, AZ 85721-0207, USA 1To

whom correspondence should be addressed

Ultraviolet B (UVB, 290–320 nm) exposure results in a variety of cellular insults including induction of cyclobutane pyrimidine dimers in DNA. Accumulation of these lesions can lead to mutations in critical genes and contribute to the development of nonmelanoma skin cancer. Topically applied α-tocopherol (vitamin E) has previously been shown to prevent the induction of skin tumors in UVB irradiated female C3H/HeNTac mice. We hypothesized that α-tocopherol, which absorbs strongly in the UVB, may act as a sunscreen to prevent photodamage. To explore possible mechanisms of photoprotection, we topically applied αtocopherol dispersed in a neutral cream vehicle to the dorsal epidermis of female C3H/HeNTac mice and exposed them to 2.5 J/m2/s of UVB for 60 min. Immediately after exposure, we analyzed thymine dimer levels in DNA by capillary gas chromatography with electron capture detection. Epidermal DNA from mice receiving this UVB dose contained 247 6 42 pmol thymine dimers/µmol thymine. Topical application of α-tocopherol inhibited dimer formation in a dose-dependent manner. A 1% α-tocopherol dispersion inhibited the formation of thymine dimers to 43% of levels in vehicle controls. Several vitamin E compounds, including α-tocopherol acetate, α-tocopherol methyl ether, γ-tocopherol, and δ-tocopherol also inhibited thymine dimer formation, but were five- to ten-fold less potent than α-tocopherol. A variety of commercially available sunscreens were also less potent than α-tocopherol in their ability to reduce dimer formation. These results suggest that DNA photoprotection is an important mechanism by which topically applied α-tocopherol can inhibit UVB induced skin cancer. α-Tocopherol acetate, the most common form of vitamin E in commercial skin care products, conferred less protection, perhaps due to its lower absorptivity in the UVB. Our results further underscore the importance of determining which forms of vitamin E can inhibit specific lesions involved in photocarcinogenesis. Introduction

© Oxford University Press

Materials and methods

1617

M.McVean and D.C.Liebler Louis, MO). α-Tocopherol methyl ether (αTOMe) was synthesized from R,R,R-αTH by Drs Yushun Li and Eugene Mash at the Southwest Environmental Health Sciences Center Synthetic Core Laboratory. αTOMe was prepared by potassium hydroxide-catalyzed alkylation of αTH by methyl iodide in dimethylsulfoxide. Comparison of UV spectra A 500 µM solution in methanol of each tocopherol derivative was scanned for absorbance in the UV range using a Beckman 640B spectrophotometer (Beckman Instruments, Fullerton, CA). Although this amount depicted ~44 times less tocopherol than a topically applied 10% dispersion (w/w) contained, this concentration was used to compare the absorbance properties of these compounds within the linear range for Beer’s law. Topical treatments and UVB irradiation Female C3H/HeNTac mice (Taconic, Germantown, NY), 10–14 weeks old, were used in all experiments. Four mice per test group were analyzed and results confirmed in duplicate experiments. Test compounds were mixed in a neutral cream vehicle, Vanicream (Pharmaceutical Specialties, Inc., Rochester, MN), in 1%215% (w/w) dispersions. Commercial SPF rated sunscreen products were applied as prepared by the manufacturer. An aliquot containing 50 mg of cream was applied to a 3 cm 3 4 cm shaved area of the back of each mouse 15 min prior to irradiation. Controls received vehicle only. No significant difference in dimer levels between vehicle treated and untreated controls was detected (not shown). A bank of six Westinghouse FS20 lamps (National Biological Corp., Twinburg, OH) which emit 80% of their output in the UVB, ,1% in the UVC, 4% in the UVA, and the remainder in the visible spectrum were used as the UV source. These lamps have been used in numerous photocarcinogenesis and sunscreen studies (18,21,22). Lamps were mounted 19.5 cm above the cage bottom and emitted a dose of 2.5 J/m2/s as measured by a UVX radiometer (UVP, Inc., San Gabriel, CA). Mice were irradiated for 60 min. A dose response study (not shown) determined that this UVB dose induced dimers to a level sufficient to accurately assess inhibition of dimers by the test compounds. This dose is also similar to that used daily in previous photocarcinogenesis studies with tocopherols and their derivatives (21,22). Dimer inhibition studies also were performed using cutoff filters (Eastman Kodak Co., Rochester, NY) which block wavelengths lower than 285 nm to simulate ‘pure’ UVB. In these studies, increasing amounts of αTH were topically applied as before. Mice were placed in cages which were covered with filters and exposed to FS20 lamps at a dose of 2.5 J/m2/s for 2 h. During irradiation, it is possible that some of the topically applied αTH is photooxidized. Previous experiments show that αTH is rapidly depleted in UVB irradiated liposomes containing αTH (24). The resulting αTH photoproducts may contribute to sunscreening activity since some of these products, including tocopherol quinone, tocopherol quinone epoxides, and a dihydroxy dimer of αTH absorb in or near the UVB. DNA preparation After irradiation, mice were killed by CO2 asphyxiation, their dorsal skin was removed and the epidermal cells were isolated by a previously described method (25). Briefly, skin was placed in 55°C water for 35 s then immersed in ice water for 1.5 min. The epidermal cells were then scraped away from the dermis and frozen immediately at 270°C until DNA extraction could be performed. Epidermal cells were isolated and frozen within 30 min post-UVB exposure. DNA was extracted with the G-NOME kit (Bio 101, Inc., La Jolla, CA). Approximately 50 µg DNA was subjected to hydrolysis in 88% formic acid at 125°C for 20 min. This hydrolysate was evaporated in vacuo and resuspended in 150 µl of distilled water. Thymine dimer analysis Thymine dimers were analyzed by a previously described method (26) with modifications. Following hydrolysis, the dimer-containing fraction was separated from unmodified bases by reverse phase HPLC with a Spherisorb ODS-2, 5 µm, 250 3 4.6 mm column, eluted with 100% water at a flow rate of 1.5 ml min21. The dimer eluted at ~8.5 min and was detected by UV absorbance at 215 nm. This fraction was evaporated and resuspended in 140 µl acetonitrile. Potassium carbonate crystals (15 mg) and 6 µmol pentafluorobenzyl bromide were added and the reaction mixture was heated to 90°C for 6 h. Samples were then evaporated under nitrogen and were resuspended in toluene. Analysis of the pentafluorobenzyl derivative of the dimer was done by capillary gas chromatography with electron capture detection on a Hewlett Packard 5890 Series II gas chromatograph equipped with an HP7673 autosampler (Hewlett Packard, Palo Alto, CA). Samples were introduced by on-column injection and analyzed with a 10 m Hewlett Packard DB-5 column, 0.53 mm I.D. with a 1.5 mm film thickness. The temperature was held isothermally at 100°C for 1 min and then programmed at 12°C min21 to 280°C, where it was held for 32 min. The dimer eluted at

1618

~25 min. A calibration curve was constructed with authentic dimer subjected to the same derivatization and analysis protocol. Control experiments (not shown) established that the dimer was stable under the conditions used for DNA hydrolysis and workup. The limit of quantitation was 1 fmol injected dimer. Dimer levels were normalized to thymine content. An aliquot of the hydrolysate was removed and 26 pg 5-ethyluracil was added as an internal standard. Thymine and 5-ethyluracil were analyzed on a Spherisorb ODS-2, 5 µm, 250 3 4.6 mm column with 5 mM KH2PO4, pH 7 and methanol (98:2, v/v) as the mobile phase. Pyrimidines were detected by monitoring UV absorbance at 260 nm. Dimers were expressed as pmol thymine dimer/µmol thymine in the same DNA hydrolysate. Statistical analysis Results were analyzed for statistical significance by ANOVA. Treatment groups were compared to control values.

Results Comparison of UV spectra of tocopherols and derivatives The absorbance spectra of αTH, αTAc, and αTOMe at equimolar concentrations in methanol are depicted in Figure 1. αTAc and αTOMe had less total absorbance within the UVB range than did αTH. Their absorbance maxima are at lower wavelengths and their molar absorptivities are lower than for αTH. UV spectra of αTH, γTH, and δTH at equimolar concentrations in methanol are depicted in Figure 2. The absorbance maxima for all three tocopherols lies within the lower UVB range. However, the molar absorptivities of γTH and δTH were higher than for αTH, as were their total absorbances within the UVB range. Rationale for selection of UV irradiation source and roles of UV wavelengths in dimer formation Mice were irradiated with Westinghouse FS20 sunlamps, which have been used as UV sources in previous photocarcinogenesis studies involving αTH and its derivatives and sunscreen studies. These lamps cannot be considered ‘pure’ UVB sources. In the description of our experiments, the term ‘UVB’ is an operational designation for the principal wavelength output from the FS20 lamps. Output in the UVA and visible wavelengths from these lamps may contribute to photocarcinogenesis, but not significantly to dimer induction. The small fraction of emission in the upper UVC (~270–290 nm) contributes significantly to dimer yield, as indicated by control experiments in which irradiation through a 285 nm cutoff filter (Eastman Kodak Co., Rochester, NY) reduced dimer yields by ~89% (not shown). Dimer induction thus can be attributed to a combination of UVB and upper UVC irradiation. Inhibition of thymine dimer formation by αTH Mice were irradiated with a UVB dose that, when given chronically, induced skin cancer in mice (21). A 60 min exposure to 2.5 J/m2/s UVB resulted in the formation of 247 6 42 pmol thymine dimers/µmol thymine. Topical application of αTH in a neutral cream dispersion caused a dose dependent inhibition of thymine dimer formation in epidermal DNA (Figure 3). Significant inhibition (P , 0.05) was observed with dispersions containing 1% or more αTH (w/w). A 1% αTH dispersion reduced dimer formation to 43% of control. The maximum reduction observed was 84% less than controls which was attained at 10% (w/w) αTH. The UVC portion of the FS20 lamps contributes significantly to dimer induction. Since human exposure to UVC is limited, it was important to confirm that αTH could protect against dimer induction by wavelengths solely in the UVB or higher. Application of αTH and subsequent irradiation through a

α-Tocopherol and DNA photodamage

Fig. 1. The UV absorbance spectra of αTH derivatives at a concentration of 500 µM in methanol. Absorbance spectra of αTH (solid line), αTAc (dotted line), and αTOMe (dashed line) and the wavelength limits of the UVB range are depicted.

Fig. 2. The UV absorbance spectra of αTH, γTH and δTH at a concentration of 500 µM in methanol. Absorbance spectra of αTH (dashed line), γTH (solid line), and δTH (dotted line) and the wavelength limits of the UVB range are depicted.

285 nm cutoff filter demonstrated that αTH inhibits the formation of dimers induced by UV wavelengths higher than 285 nm (Figure 4) in a dose dependent manner. A 1% dispersion (w/w) of αTH reduced dimers to 60% of control and a 10% dispersion significantly reduced dimers to 17% of control (P , 0.01). Since αTH acted similarly as a sunscreen in both filtered and unfiltered irradiations, subsequent irradiations were carried out using unfiltered FS20 sources. Inhibition of thymine dimer formation by different forms of αTH Dispersions containing αTAc also produced dose-dependent inhibition of dimer formation, although the effect was smaller

Fig. 3. Inhibition of UVB induced thymine dimers in mouse epidermal DNA by αTH. C3H/HeN mice were treated with increasing concentrations of αTH. They were then exposed to UVB and epidermal DNA was analyzed for thymine cyclobutane dimers as described under Materials and methods. Each bar represents mean 6 standard deviation for four animals. Statistically significant differences compared to controls are indicated (*P , 0.05, **P , 0.01).

Fig. 4. Inhibition of thymine dimers induced by filtered UVB sources in mouse epidermal DNA by αTH. C3H/HeN mice were treated with increasing concentrations of αTH. They were then exposed to UVB filtered through 285 nm cutoff filters. Epidermal DNA was analyzed for thymine cyclobutane dimers as described under Materials and methods. Each bar represents mean 6 standard deviation for four animals. Statistically significant differences compared to controls are indicated (**P , 0.01).

than that observed with equivalent amounts of αTH (Figure 5). A 10% (w/w) dispersion of αTAc was necessary to inhibit dimer formation to 44% of controls, which is comparable to the inhibition produced by 1% αTH. Other forms of vitamin E were similarly studied (Figure 6). αTOMe is spectrally similar to αTAc but is not hydrolyzed to αTH. This allowed us to investigate whether hydrolysis of the acetate ester to form free αTH is necessary for the sunscreening effect. A 10% (w/w) αTOMe dispersion conferred a 50% inhibition of dimer formation (P , 0.05) which is similar to that produced by both 10% αTAc and 1% αTH. Both γTH and δTH were less potent sunscreens than αTH. Dispersions containing 5% (w/w) γTH or δTH significantly (P , 0.05) 1619

M.McVean and D.C.Liebler

Fig. 5. Inhibition of UVB induced thymine dimers in mouse epidermal DNA by αTAc. C3H/HeN mice were treated with increasing concentrations of αTAc. They were then exposed to UVB and epidermal DNA was analyzed for thymine cyclobutane dimers as described under Materials and methods. Each bar represents mean 6 standard deviation for four animals. Statistically significant differences compared to controls are indicated (**P , 0.01).

Fig. 7. Inhibition of UVB induced thymine dimers in mouse epidermal DNA by commercial sunscreens. C3H/HeN mice were treated with increasing concentrations of PABA or commercial sunscreens with increasing SPF ratings. They were then exposed to UVB and epidermal DNA was analyzed for thymine cyclobutane dimers as described under Materials and methods. Each bar represents mean 6 standard deviation for four animals. Statistically significant differences compared to controls are indicated (*P , 0.05, **P , 0.01, ***P , 0.001).

dimer formation similar to that of the 1% (w/w) αTH dispersion (Figure 7). The SPF 8 sunscreen reduced dimers to 48% of control. However, statistically significant protection was seen only with the SPF 15 (P , 0.05) and SPF 30 (P , 0.01) preparations, each of which contained octyl methoxycinnamate, octyl salicylate, and oxybenzone. Discussion

Fig. 6. Inhibition of UVB induced thymine dimers in mouse epidermal DNA by other tocopherol derivatives. C3H/HeN mice were treated with increasing concentrations of tocopherol derivatives. They were then exposed to UVB and epidermal DNA was analyzed for thymine cyclobutane dimers as described under Materials and methods. Each bar represents mean 6 standard deviation for four animals. Statistically significant differences compared to controls are indicated (*P , 0.05).

reduced dimer formation to 45% of control, which was similar to the level of inhibition produced by 1% αTH. Inhibition of thymine dimers by PABA and commercial sunscreens The prototypical sunscreening agent PABA also was evaluated. Once widely used, this compound induced skin hypersensitivity reactions and increased DNA photodamage in vitro (27,28) and is no longer used in sunscreen products. Application of PABA resulted in a dose-dependent inhibition of dimers (Figure 7). A 10% (w/w) dispersion was necessary to produce significant (P , 0.01) inhibition of dimer formation. This dose reduced dimers to 51% of control, which is similar to the reduction produced by the 1% αTH dispersion. The sunscreen products used contained proprietary formulations of oxybenzone, octyl methoxycinnamate, octyl salicylate, or PABA esters as active ingredients. Application of a sunscreen containing octyl dimethyl PABA and oxybenzone and rated with a sun protection factor (SPF) 8 provided protection against 1620

We have demonstrated that topical application of naturally occurring αTH and several of its derivatives can inhibit the formation of thymine dimers in epidermal DNA of UVB irradiated mice. Photodimerization serves as a more specific indicator of UVB energy deposition into DNA than more frequently assessed endpoints, such as edema and erythema. Those endpoints represent complex events resulting from numerous responses elicited by irradiation. Some sunscreens have previously been evaluated for their ability to inhibit the formation of pyrimidine dimers (18). Here we report that αTH and several of its derivatives compare favorably with commercially available sunscreens in their ability to prevent UVB induced DNA photodamage. Although the lamps used in this study emit light primarily in the UVB, they also emit light in both the UVA and UVC. We have shown that αTH protects against dimer formation induced by both unfiltered sources and by irradiation through a filter that excludes wavelengths lower than 285 nm. As noted in the Results section, however, the contribution of a relatively small amount of UVC to cyclobutane dimer induction is significant. Our experiments with unfiltered FS20 lamps suggest that the photoprotective effect exerted by the compounds tested extends into UVC wavelengths also. Thus, the data obtained in these studies probably provides an accurate indication of the ability of αTH, its derivatives, and sunscreens to inhibit thymine dimer formation induced by any of the UV components of sunlight. Furthermore, the Westinghouse FS20 lamps are widely used in carcinogenesis studies and αTH was shown to prevent photocarcinogenesis induced with these light sources. Historically, the protective effects of αTH have been attrib-

α-Tocopherol and DNA photodamage

uted to its radical scavenging activity. αTH is the primary lipid soluble chain breaking antioxidant in cells (29). Consequently, αTH or its more thermally stable derivative, αTAc, is often added to skin care products as an antioxidant supplement. However, the direct sunscreening effect of αTH demonstrated here is a striking addition to the growing list of effects αTH has on general cellular function. αTH and certain tocopherol derivatives can modify signal transduction pathways (30,31), improve immune responsiveness (32,33), inhibit platelet phospholipase A2 (34) and suppress proliferation of certain cell types in vitro (35–37). All of these actions may contribute to their antitumorigenic and photoprotective potential. Our results suggest, however, that prevention of DNA photodamage may account for much of the antitumor effect of topically applied αTH in photocarcinogenesis. Furthermore, prevention of DNA photodamage may reflect reduced incident UVB penetration into the epidermis and dermis. Therefore, the photoprotective effect of αTH may extend to prevention of other types of DNA photodamage and of damage to biomolecules involved in UVB-associated responses. It is reasonable that αTH could inhibit the formation of pyrimidine (6–4) pyrimidone photoproducts, since they form through similar UV induced photochemistry, and perhaps DNA photohydrates. Furthermore, topical application of αTH has been shown to reduce UVB induced immunosuppression (21). Photoprotection also may involve prevention of acute responses including activation of growth related genes such as c-fos (38) and c-H-ras (39). This could prevent early alterations in cellular metabolism that promote tumor formation. Manifestations of chronic UVB exposure, such as solar elastosis and dermal degeneration (40) also could be attenuated. αTH may actually be a more effective DNA photoprotectant than the active ingredients in sunscreen preparations. A dispersion containing 1% αTH was as potent as products containing multiple sunscreening agents. Thus, a particular combination or higher concentrations of these sunscreening agents may be necessary to reach the same level of protection demonstrated by αTH. Further investigations of αTH and specific sunscreen components are underway in our laboratory to examine this issue. Despite the structural similarity between the forms of vitamin E tested, αTH is a more potent inhibitor of DNA photodamage than the other tocopherols examined. Since αTAc may be hydrolyzed in cells to form αTH, the sunscreening effect exerted by αTAc could depend in part on its hydrolysis to αTH. Experiments with the non-hydrolyzable tocopherol derivative αTOMe indicated, however, that hydrolysis may not be necessary. Equal concentrations of αTOMe and αTAc, which have nearly identical spectral properties, produced a similar degree of inhibition of dimer formation. Thus, hydrolysis to αTH may not contribute significantly to the photoprotective effect of αTAc when acutely applied. It is particularly interesting that αTH is ~five times more potent than γTH and δTH. This is surprising since both γTH and δTH have slightly greater absorbances within the UVB range than αTH. However, bioassay comparisons of the various tocopherols indicated that αTH had the highest biological vitamin E activity (41,42). Binding proteins specific for αTH also have been isolated from membrane fractions of human erythrocytes (43), from the cytosol of rat liver and heart (44), from bovine aortic endothelial cells (45), from bovine (46) and rabbit heart cytosol (47) and human liver (48). These purified proteins bind αTH in preference to δTH and γTH.

Thus, the αTH form may be preferentially absorbed by cells and more effectively distributed to critical intracellular targets. Our findings emphasize the need to ascertain which forms of tocopherol are active photoprotectants. Although αTH is a superior sunscreen and antioxidant, the thermally stable αTAc derivative is more commonly used in sunscreen preparations and other skin care products. However, recent work by Gensler et al. (22) indicated that whereas topically applied αTH prevented UVB photocarcinogenesis, neither αTAc nor αTS did so under the same conditions. Our results provide a plausible mechanistic explanation for these differences. Our studies indicate a novel mechanism by which αTH can inhibit photocarcinogenesis. The ability to attenuate DNA damage could prevent mutations in critical genes associated with photocarcinogenesis. Thus, the sunscreening activity of αTH may be as important as antioxidant activity in preventing cellular damage and tumor formation. Further studies will be needed to explain why αTH exhibits superior sunscreening actions over other tocopherols and commercial sunscreens in vivo. Acknowledgement This work was supported by NIH grants CA59585 and ES06694.

References 1. Matsui,M.S. and DeLeo,V.A. (1995) Photocarcinogenesis by ultraviolet A and B. In Mukhtar,H. (ed.), Skin Cancer: Mechanisms and Human Relevance. CRC Press, Ann Arbor, MI, pp. 21–30. 2. Franklin,W.A., Lo,K.M. and Haseltine,W.A. (1982) Alkaline lability of fluorescent photoproducts produced in ultraviolet light-irradiated DNA. J. Biol. Chem., 257, 13535–13543. 3. Miller,J.H. (1985) Mutagenic specificity of ultraviolet light. J. Mol. Biol., 182, 45–68. 4. Brash,D.E., Rudolph,J.A., Simon,J.A., Lin,A., McKenna,G.J., Baden,H.P., Halperin,A.J. and Ponten,J. (1991) A role for sunlight in skin cancer: UVinduced p53 mutations in squamous cell carcinoma. Proc. Natl Acad. Sci. USA, 88, 10124–10128. 5. Nakazawa,H., English,D., Randell,P.L., Nakazawa,K., Martel,N., Armstrong,B.K. and Yamasaki,H. (1994) UV and skin cancer: specific p53 gene mutations in normal skin as a biologically relevant exposure measurement. Proc. Natl Acad. Sci. USA, 9, 360–364. 6. Pierceall,W.E., Mukhopadhyay,T., Goldberg,L.H. and Ananthaswamy,H.N. (1991) Mutations in the p53 tumor suppressor gene in human cutaneous squamous cell carcinomas. Mol. Carc., 4, 445–449. 7. Torinuki,W., Miura,T. and Seiji,M. (1980) Lysosome destruction and lipoperoxide formation due to active oxygen generated from haematoporphyrin and UV irradiation. Brit. J. Derm., 102, 17–27. 8. Potokar,M., Holtzmann,W. and Werner-Busse,A. (1990) Effectiveness of vitamin E protecting against UV-light—Comparative testing of the natural tocopherol on the skin of the hairless mouse. Fett. Wiss. Technol., 92, 406–410. 9. Trevithick,J.R., Xiong,H., Lee,S., Shum,D.T., Sanford,S.E., Karlik,S.J., Norley,C. and Dilworth,G.R. (1992) Topical tocopherol acetate reduces post-UVB, sunburn-associated erythema, edema, and skin sensitivity in hairless mice. Arch. Biochem. Biophys., 296, 575–582. 10. Record,I.R., Dreosti,I.E., Konstantinopoulos,M. and Buckley,R.A. (1991) The influence of topical and systemic vitamin E on ultraviolet lightinduced skin damage in hairless mice. Nutr. Canc., 16, 219–225. 11. Elmets,C.A. and Anderson,C.Y. (1996) Sunscreens and photocarcinogenesis: an objective assessment. Photochem. Photobiol., 63, 435–440. 12. Pathak,M.A. and Stratton,K. (1968) Free radicals in human skin before and after exposure to light. Arch. Biochem. Biophys., 123, 468–476. 13. Gilchrest,B.A., Soter,N.A., Stoff,J.S. and Mihm,M.C. (1981) The human sunburn reaction: histologic and biochemical studies. Am. Acad. Dermatol., 5, 411–422. 14. Soter,N.A. (1990) Acute effects of ultraviolet radiation of the skin. Semin. Derm., 9, 11–15.

1621

M.McVean and D.C.Liebler 15. De Rijcke,S. and Henen,M. (1989) Decrease of ultraviolet-induced DNA injury in human skin by p-aminobenzoic acid esters. Dermatol., 179, 196–199. 16. Freeman,S.E., Ley,R.D. and Ley,K.D. (1988) Sunscreen protection against UV-induced pyrimidine dimers in DNA of human skin in situ. Photoderm., 5, 243–247. 17. Lowe,N.J. and Breeding,J. (1980) Evaluation of sunscreen protection by measurement of epidermal DNA synthesis. J. Invest. Derm., 74, 181–182. 18. Wolf,P., Yarosh,D.B. and Kripke,M.L. (1993) Effects of sunscreens and a DNA excision repair enzyme on ultraviolet radiation-induced inflammation, immune suppression, and cyclobutane pyrimidine dimer formation in mice. J. Invest. Derm., 101, 523–527. 19. Snyder,D.S. and Mary,M. (1975) Ability of PABA to protect mammalian skin from ultraviolet light-induced skin tumors and actinic damage. J. Invest. Derm., 65, 543–546. 20. Kligman,L.H., Akin,F.J. and Kligman,A.M. (1980) Sunscreens prevent ultraviolet photocarcinogenesis. Am. Acad. Dermatol., 3, 30–35. 21. Gensler,H.L. and Magdaleno,M. (1991) Topical vitamin E inhibition of immunosuppression and tumorigenesis induced by ultraviolet irradiation. Nutr. Canc., 15, 97–106. 22. Gensler,H.L., Aickin,M., Peng,Y. and Xu,M. (1996) Importance of the form of topical vitamin E for prevention of photocarcinogenesis. Nutr. Canc., 26, 183–191. 23. Sage,E. (1993) Distribution and repair of photolesions in DNA: genetic consequences and the role of sequence context. Photochem. Photobiol., 57, 163–174. 24. Kramer,K.A. and Liebler,D.C. (1997) UVB induced photooxidation of vitamin E. Chem. Res. Tox., 10, 219–224. 25. Thompson,S. and Slaga,T.J. (1976) Mouse epidermal aryl hydrocarbon hydroxylase. J. Invest. Derm., 66, 108–111. 26. Ramsey,R.S. and Ho,C.-H. (1989) Determination of pyrimidine dimers in DNA by high-performance liquid chromatography/gas chromatography and electron capture detection. Anal. Biochem., 18, 424–431. 27. Sutherland,J.C. and Griffin,K.P. (1984) p-Aminobenzoic acid can sensitize the formation of pyrimidine dimers in DNA: Direct chemical evidence. Photochem. Photobiol., 4, 391–394. 28. Sutherland,B.M. (1982) p-Aminobenzoic acid-sunlamp sensitization of pyrimidine dimer formation and transformation in human cells. Photochem. Photobiol., 36, 95–97. 29. Burton,G.W., Joyce,A. and Ingold,K.U. (1983) Is vitamin E the only lipidsoluble, chain-breaking antioxidant in human blood plasma and erythrocyte membranes? Arch. Biochem. Biophys., 221, 281–290. 30. Chatelain,E., Boscoboinik,D.O., Bartoli,G.M., Kagan,V.E., Gey,F.K., Packer,L. and Azzi,A. (1993) Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienols. Biochim. Biophys. Acta, 1176, 83–89. 31. Suzuki,Y.J. and Packer,L. (1993) Inhibition of NF-κB activation by vitamin E derivatives. Biochem. Biophys. Res. Commun., 193, 277–283. 32. Corwin,L.M. and Shloss,J. (1980) Influence of vitamin E on the mitogenic response of murine lymphoid cells. J. Nutr., 110, 916–923. 33. Meydani,S.N., Barklund,M.P., Liu,S., Meydani,M., Miller,R.A., Cannon,J.G., Morrow,F.D., Rocklin,R. and Blumberg,J.B. (1990) Vitamin E supplementation enhances cell-mediated immunity in healthy elderly subjects. Am. J. Clin. Nutr., 52, 557–563. 34. Douglas,C.E., Chan,A.C. and Choy,P.C. (1986) Vitamin E inhibits platelet phospholipase A2. Biochim. Biophys. Acta, 876, 639–645. 35. Boscoboinik,D., Szweczyk,A., Hensey,C. and Azzi,A. (1991) Inhibition of cell proliferation by α-tocopherol. J. Biol. Chem., 266, 6188–6194. 36. Kline,K., Cochran,G.W. and Sanders,B.G. (1990) Growth-inhibitory effects of vitamin E succinate on retrovirus-transformed tumor cells in vitro. Nutr. Canc., 14, 27–41. 37. Prasad,K.N. and Edwards-Prasad,J. (1982) Effects of tocopherol (vitamin E) acid succinate on morphological alterations and growth inhibition in melanoma cells in culture. Cancer Res., 42, 550–555. 38. Shah,G., Ghosh,R., Amstad,P.A. and Cerutti,P.A. (1993) Mechanism of induction of c-fos by ultraviolet B (290–320 nm) in mouse JB6 epidermal cells. Cancer Res., 53, 38–45. 39. Ronai,Z.A., Okin,E. and Weinstein,I.B. (1988) Ultraviolet light induces the expression of oncogenes in rat fibroblast and human keratinocyte cells. Oncogene, 2, 210–214. 40. Kligman,L.H., Akin,F.J. and Kligman,A.M. (1982) Prevention of ultraviolet damage of the dermis of hairless mice by sunscreens. J. Invest. Derm., 78, 181–189. 41. Bunyan,J., McHale,D., Green,J. and Marcinkiewicz,S. (1961) Biological potencies of ε- and ζ-tocopherol and 5-methyltocol. Brit. J. Nutr., 15, 253–257. 42. Burton,G.W. and Ingold,K.U. (1981) Autoxidation of biological molecules.

1622

1. The antioxidant activity of vitamin E and related chain-breaking phenolic antioxidants in vitro. J. Am. Chem. Soc., 103, 6472–6477. 43. Wimalasena,J., Davis,M. and Kitabchi,A.D. (1982) Characterization and solubilization of the specific binding sites for d-α-tocopherol from human erythrocyte membranes. Biochem. Pharm., 31, 3455–3461. 44. Dutta-Roy,A.K., Leishman,D.J., Gordon,M.J., Campbell,F.M. and Duthie,G.G. (1993) Identification of a low molecular mass (14.2 kDa) αtocopherol-binding protein in the cytosol of rat liver and heart. Biochem. Biophys. Res. Commun., 196, 1108–1112. 45. Kunisaki,M., Umeda,F., Inoguchi,T. and Nawata,H. (1992) Vitamin E binds to specific binding sites and enhances prostacyclin production by cultured aortic endothelial cells. Thromb. Haem., 68, 744–751. 46. Gordon,M.J., Campbell,F.M., Duthie,G.G. and Dutta-Roy,A.K. (1995) Characterization of a novel α-tocopherol-binding protein from bovine heart cytosol. Arch. Biochem. Biophys., 318, 140–146. 47. Dutta-Roy,A.K., Gordon,M., Leishman,D.J., Paterson,B.J., Duthie,G.G. and James,W.P.T. (1993) Purification and partial characterisation of an αtocopherol-binding protein from rabbit heart cytosol. Mol. Cell. Biochem., 123, 139–144. 48. Arita,M., Sato,Y., Miyata,A., Tanabe,T., Takahashi,E., Kayden,H.J., Arai,H. and Inoue,K. (1995) Human α-tocopherol transfer protein: cDNA cloning, expression and chromosomal localization. Biochem. J., 306, 437–443. Received on January 16, 1997; revised on April 16, 1997; accepted on April 25, 1997